# Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization

> **NCT00165828** · PHASE4 · TERMINATED · sponsor: **Eisai GmbH** · enrollment: 157 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Zonegran

## Key facts

- **NCT ID:** NCT00165828
- **Lead sponsor:** Eisai GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-05
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2014-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00165828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00165828, "Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00165828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*